Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FDA extends PDUFA date for Gestiva

Jan. 17, 2011

University of Edinburgh divulges new 11-beta-HSD1 inhibitors

Jan. 17, 2011

Lupin divulges new dipeptidyl peptidase 4 inhibitors

Jan. 17, 2011

FDA accepts NDA for extended-release Janumet for review

Jan. 14, 2011

Omthera reports bioavailability data from ECLIPSE trial of Epanova

Jan. 13, 2011

Dara BioSciences presents additional data from phase I DB-959 trial

Jan. 12, 2011

EffRx Pharma submits NDA to FDA for EX-101

Jan. 12, 2011

Esperion begins phase II trial of ETC-1002 in lipid regulation

Jan. 12, 2011

Zydus-Cadila discloses new GPR119 receptor agonists

Jan. 12, 2011

New melanin-concentrating hormone MCH1 receptor antagonists disclosed

Jan. 12, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...